← Leaderboards
Klemens J Hertel
University Of California Irvine
$9,133,819
Attributed
$10,911,309
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,911,309 · 6
By mechanism
R01$8,297,734 · 3
R35$1,833,691 · 1
R21$779,884 · 2
Top collaborators
- Robert Andrew Edwards5 shared
- Yongsheng Shi5 shared
- Marian L Waterman5 shared
Most similar at University Of California Irvine
Same institution · by research overlap
- Bert L. Semler$20,880,577
- Marian L Waterman$14,719,777
- Robert Andrew Edwards$2,143,241
- Rozanne M. Sandri-Goldin$9,060,967
- Kara A Corbin-Lickfett$143,200
Others in their field
Top investigators on “Rna Splicing”
- Rolf Apweiler · European Molecular Biology Laboratory$41,336,566
- Daniel H Geschwind · University Of California Los Angeles$31,650,067
- Stacey Gabriel · Massachusetts Institute Of Technology$30,450,662
- Brenton R Graveley · University Of Connecticut Sch Of Med/Dnt$30,235,936
- Adrian R Krainer · Cold Spring Harbor Laboratory$28,755,040
- George M Church · Harvard University (Medical School)$26,862,961
Research focus
Rna SplicingInsightMrna PrecursorGene ExpressionAlternative SplicingMolecularRegulationEventSplice SiteGenesDefectIntronsLeadKineticsHuman DiseaseCellsBioinformaticsSpliceosomesSiteExonsMutationResearch StudyGene Expression ProfileGrowth
Grant awards (39)
Regulation and impact of alternative splicing in biology and disease$392,500
R35 · FY2025 · GM · contact PI
Regulation and impact of alternative splicing in biology and disease$91,157
R35 · FY2025 · GM · contact PI
Regulation and impact of alternative splicing in biology and disease$392,500
R35 · FY2024 · GM · contact PI
Regulation and impact of alternative splicing in biology and disease$91,157
R35 · FY2024 · GM · contact PI
Regulation and impact of alternative splicing in biology and disease$392,500
R35 · FY2023 · GM · contact PI
Regulation and impact of alternative splicing in biology and disease$81,377
R35 · FY2023 · GM · contact PI
Regulation and impact of alternative splicing in biology and disease$392,500
R35 · FY2022 · GM · contact PI
Mechanisms of Enhancer Dependent SpliceSite Activation$308,045
R01 · FY2019 · GM · contact PI
Coordinated regulation of alternative pre-mRNA processing in colon cancer$475,840
R01 · FY2018 · CA · contact PI
Mechanisms of Enhancer Dependent SpliceSite Activation$308,045
R01 · FY2018 · GM · contact PI
Tracking Gene Expression Dynamics from Transcription to Degradation$285,389
R01 · FY2018 · GM · contact PI
Coordinated regulation of alternative pre-mRNA processing in colon cancer$475,840
R01 · FY2017 · CA · contact PI
Mechanisms of Enhancer Dependent SpliceSite Activation$308,045
R01 · FY2017 · GM · contact PI
Tracking Gene Expression Dynamics from Transcription to Degradation$286,068
R01 · FY2017 · GM · contact PI
Coordinated regulation of alternative pre-mRNA processing in colon cancer$475,840
R01 · FY2016 · CA · contact PI
Mechanisms of Enhancer Dependent SpliceSite Activation$305,573
R01 · FY2016 · GM · contact PI
Tracking Gene Expression Dynamics from Transcription to Degradation$286,710
R01 · FY2016 · GM · contact PI
Coordinated regulation of alternative pre-mRNA processing in colon cancer$472,634
R01 · FY2015 · CA · contact PI
Tracking Gene Expression Dynamics from Transcription to Degradation$287,318
R01 · FY2015 · GM · contact PI
Coordinated regulation of alternative pre-mRNA processing in colon cancer$469,833
R01 · FY2014 · CA · contact PI
Mechanisms of Enhancer Dependent Splice Site Activation$280,622
R01 · FY2013 · GM · contact PI
Mechanisms of Enhancer Dependent Splice Site Activation$291,941
R01 · FY2012 · GM · contact PI
Mechanisms of Enhancer Dependent Splice Site Activation$298,005
R01 · FY2011 · GM · contact PI
The role of alternative pre-mRNA splicing in breast cancer progression$154,474
R21 · FY2011 · CA · contact PI
The role of alternative pre-mRNA splicing in breast cancer progression$37,132
R21 · FY2011 · CA · contact PI
Mechanisms of Enhancer Dependent Splice Site Activation$307,603
R01 · FY2010 · GM · contact PI
The role of alternative pre-mRNA splicing in breast cancer progression$193,406
R21 · FY2010 · CA · contact PI
Mechanisms of enhancer dependent splice-site activation$279,095
R01 · FY2009 · GM · contact PI
Mechanisms of enhancer dependent splice-site activation$140,251
R01 · FY2009 · GM · contact PI
Mechanisms of enhancer dependent splice-site activation$280,923
R01 · FY2008 · GM · contact PI
Genomic Analysis of Alternative Splice-Site Selection$215,574
R21 · FY2008 · GM · contact PI
Mechanisms of enhancer dependent splice-site activation$280,517
R01 · FY2007 · GM · contact PI
Genomic Analysis of Alternative Splice-Site Selection$179,298
R21 · FY2007 · GM · contact PI
Mechanisms of enhancer dependent splice-site activation$291,061
R01 · FY2006 · GM · contact PI
MECHANISMS OF ENHANCER DEPENDENT SPLICE SITE ACTIVATION$219,594
R01 · FY2005 · GM
MECHANISMS OF ENHANCER DEPENDENT SPLICE SITE ACTIVATION$220,090
R01 · FY2004 · GM
MECHANISMS OF ENHANCER DEPENDENT SPLICE SITE ACTIVATION$220,545
R01 · FY2003 · GM
MECHANISMS OF ENHANCER DEPENDENT SPLICE SITE ACTIVATION$220,962
R01 · FY2002 · GM
MECHANISMS OF ENHANCER DEPENDENT SPLICE SITE ACTIVATION$221,345
R01 · FY2001 · GM